๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Crohns Disease

A Study to Investigate Efficacy and Safety of Brivekimig in Participants With Crohn's Disease NCT06958536Phase 266 sites๐Ÿ“ Tucson๐Ÿ“ Escondido๐Ÿ“ Lancaster Sanofi ยท Tests: brivekimig, Placebo A Study of Vedolizumab in Adult Participants With Moderate to Severe Crohn's Disease NCT05837897Phase 341 sites๐Ÿ“ Hefei๐Ÿ“ Wuhu๐Ÿ“ Beijing Takeda ยท Tests: Vedolizumab IV, Placebo A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD) NCT04779320Phase 396 sites๐Ÿ“ Phoenix๐Ÿ“ Los Angeles๐Ÿ“ San Diego Takeda ยท Tests: Vedolizumab IV Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project NCT02103361n/a1 site๐Ÿ“ La Jolla University of California, San Diego ยท Tests: Ustekinumab, Guselkumab Evaluation of the Accuracy of Immunostaining of Claudin 2 to Detect Active or Inactive Inflammation in Endoscopic Biopsies of IBD NCT07710287n/a1 site๐Ÿ“ San Donato Milanese IRCCS Policlinico S. Donato Interleukin-23 Monoclonal Antibody for Inflammatory Bowel Disease: Efficacy and Safety NCT07216014Phase 41 site๐Ÿ“ Guangzhou Sixth Affiliated Hospital, Sun Yat-sen University ยท Tests: Interleukin 23, Interleukin 23 Digestive Evolution of Children With Crohn's Disease or Ulcerative Colitis Whose Anti-TNFฮฑ Treatment Was Switched to Ustekinumab Due to Paradoxical Psoriasis, NCT07529236NA1 site๐Ÿ“ Nice Centre Hospitalier Universitaire de Nice ยท Tests: switch of anti TNF for ustekinumab for paradoxical psoriasis. Risankizumab for Refractory Perianal Fistulizing Crohn's Disease NCT07872449Phase 44 sites๐Ÿ“ Nishinomiya๐Ÿ“ Shinjuku-Ku๐Ÿ“ Yokohama Yuki Horio ยท Tests: Risankizumab Longitudinal Study on Bacterial Production of LPC and LPA in Patients With Inflammatory Bowel Disease NCT06548399n/a1 site๐Ÿ“ Hamilton McMaster University Endoscopic Stricturotomy Versus Balloon Dilation for Small Bowel Fibrotic Strictures in Crohn's Disease NCT07833332NA1 site๐Ÿ“ Guangzhou Sixth Affiliated Hospital, Sun Yat-sen University ยท Tests: Endoscopic Stricturotomy, Endoscopic Balloon Dilation Exploring Fecal Calprotectin Levels, Maternal and Infant Microbiota, Infant Health, Nutrition, and Adverse Pregnancy Outcomes With Patient With Inflammatory Bowel Disease NCT07385807n/a2 sites๐Ÿ“ Vancouver๐Ÿ“ Vancouver University of British Columbia Pregnancy and Inflammatory Bowel Disease NCT07377188n/a1 site๐Ÿ“ Amiens Centre Hospitalier Universitaire, Amiens An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease NCT07184931Phase 3461 sites๐Ÿ“ Peoria๐Ÿ“ Scottsdale๐Ÿ“ Scottsdale Sanofi ยท Tests: Duvakitug, Placebo A Phase I Study to Evaluate the Safety/Tolerability of BDHK-2009 Tablets in Healthy Adult NCT07632573Phase 11 site๐Ÿ“ Hangzhou Benethera (Shaoxing) Biotechnology Co., Ltd. ยท Tests: BDHK-2009 Tablets, Placebo Leucine-rich ฮฑ2-glycoprotein Correlation With Clinical, Endoscopic and Histological Disease Activity of IBD in a EuRopean Context NCT07621783n/a1 site๐Ÿ“ Bonheiden Imelda GI Clinical Research Center ยท Tests: Leucine-rich ฮฑ2-glycoprotein Impact of a Structured Therapeutic Education Session on the Practice of Adapted Physical Activity in Chronic Inflammatory Bowel Diseases NCT07305454n/a1 site๐Ÿ“ Toulouse University Hospital, Toulouse ยท Tests: Inflammatory Bowek Disk Questionnaires, Short-International Physical Activity Questionnaries High Dose Interval Vitamin D Supplementation in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy NCT04331639n/a1 site๐Ÿ“ Boston Boston Children's Hospital ยท Tests: vitamin D3 A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease NCT05995353Phase 385 sites๐Ÿ“ Phoenix๐Ÿ“ Little Rock๐Ÿ“ Oakland AbbVie ยท Tests: Risankizumab, Risankizumab A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease NCT07483073Phase 270 sites๐Ÿ“ Scottsdale๐Ÿ“ Los Angeles๐Ÿ“ Oxnard Eli Lilly and Company ยท Tests: Mirikizumab - Intravenous (IV), Mirikizumab - Subcutaneous (SC), LY4395089 Efficacy and Safety of Upadacitinib in Inflammatory Bowel Disease NCT06780683n/a6 sites๐Ÿ“ Guangzhou๐Ÿ“ Guangzhou๐Ÿ“ Meizhou Xiang Gao ยท Tests: Upadacitinib Study of the Kono-S Anastomosis Versus the Side-to-side Functional End Anastomosis NCT03256240NA15 sites๐Ÿ“ Boston๐Ÿ“ New York๐Ÿ“ Oklahoma City Weill Medical College of Cornell University ยท Tests: side-to-side functional end anastomosis, Kono-S analstomosis TIDHI Mental Health in IBD Patients Study NCT07013578NA1 site๐Ÿ“ North York TIDHI Innovation Inc. ยท Tests: Healing Circuitsโ„ข sessions, self-directed Healing Circuitsโ„ข curriculum Lesion Size Measurement During Gastrointestinal Endoscopies NCT07770425n/a1 site๐Ÿ“ Montreal Centre hospitalier de l'Universitรฉ de Montrรฉal (CHUM) Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) and Diet in Inflammatory Bowel Disease (IBD) Patients NCT06774079Phase 41 site๐Ÿ“ Miami University of Miami ยท Tests: Tirzepatide, Mediterranean diet Prospective Evaluation of the Carbon Footprint and Clinical Utility of IBUS Compared to Colonoscopy and Enterography in UC and CD NCT07431983n/a2 sites๐Ÿ“ Hyderabad๐Ÿ“ Hyderabad Asian Institute of Gastroenterology, India CEDUR - German IBD Registry NCT07319442n/a1 site๐Ÿ“ Hamburg ImmunoRegister gUG Testing the Role of Anti-fungal Therapy in Improving the Response to Therapies for Crohn's Disease NCT06274554Phase 31 site๐Ÿ“ New York Weill Medical College of Cornell University ยท Tests: Fluconazole, Placebo, IL-23 Therapy A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD) NCT06764615Phase 216 sites๐Ÿ“ Glen Burnie๐Ÿ“ Tyler๐Ÿ“ Chongqing Takeda ยท Tests: Zasocitinib Intestinal Ultrasound Guided Management in Inflammatory Bowel Disease NCT07775352NA1 site๐Ÿ“ Bangkok Mahidol University ยท Tests: Intestinal ultrasound (IUS), Standard of care DB-3Q for the Treatment of Medically Refractory Crohn's Disease NCT07625293Phase 21 site๐Ÿ“ St Louis Direct Biologics, LLC ยท Tests: DB-3Q, Placebo
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy